Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Diagnosis of X-linked hypophosphatemia (XLH) usually begins with blood and urine tests showing low serum phosphate, high phosphate loss in the urine, elevated FGF23, and normal or low active vitamin D with normal calcium, followed by X-rays or skeletal imaging that reveal rickets, bowed legs, or osteomalacia. Genetic testing for a PHEX gene mutation confirms the diagnosis, and family history matters because XLH is inherited in an X-linked dominant pattern, though about one in three cases occur with no family history. Because XLH is often mistaken for nutritional rickets, growth delay, or ordinary joint pain, many people wait years for an answer, so specialist referral to an endocrinologist, nephrologist, or geneticist is often the turning point. There are several factors that affect how quickly XLH is identified in children versus adults, and important testing details are explained below.
If you or your child has unexplained bowed legs, short stature, bone or joint pain, dental abscesses, or hearing changes, a free, instant, online symptom check can help you organize your symptoms, see which conditions may fit the pattern, and walk into your next appointment ready to ask for the specific phosphate and genetic tests that lead to a clear diagnosis.
Last reviewed for medical accuracy: 08/18/2026
X-linked hypophosphatemia (XLH) is a rare inherited disorder that affects the body’s ability to balance phosphate. Phosphate is vital for strong bones, muscle function, and overall health. Early diagnosis of x linked hypophosphatemia helps guide treatment, support growth in children, and reduce long-term complications.
XLH symptoms can vary by age. Not everyone has every sign, but common features include:
Children
Adults
Family History
Diagnosis of x linked hypophosphatemia is based on a combination of clinical evaluation, laboratory tests, imaging studies, and genetic testing.
Key laboratory values in XLH often include:
These tests help confirm chronic phosphate wasting rather than dietary deficiency.
Other causes of rickets or osteomalacia must be ruled out:
Accurate diagnosis ensures the correct treatment plan.
Once x linked hypophosphatemia is confirmed, a care plan typically involves:
Regular follow-up with a multidisciplinary team (endocrinologist, nephrologist, orthopedist, dentist) ensures treatment stays on track.
Lifelong monitoring is essential to adjust therapy and detect complications early:
While XLH itself is rarely life-threatening, complications or other symptoms may require urgent care. Speak to a doctor if you or your child experiences:
Anything that feels serious or life-threatening should be evaluated right away by a healthcare professional.
If you’re unsure whether your symptoms fit x linked hypophosphatemia or another condition, you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you organize your concerns before speaking with a healthcare provider.
👉 Free, online symptom check, using the doctor approved Ubie Symptom Checker
Always consult your doctor for anything serious or life-threatening. Early diagnosis and a solid care plan can make a significant difference in managing x linked hypophosphatemia and maintaining a good quality of life.
(References)
* Baroncelli GI, Toschi B, Bertelloni S. Hypophosphatemic rickets. Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):460-7. doi: 10.1097/MED.0b013e328358be97. PMID: 23108197.
* Haffner D, Emma F, Eastwood DM, Biosse Duplan M, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. PMID: 31068690; PMCID: PMC7136170.
* Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet. 2019 Jun 15;393(10189):2416-2427. doi: 10.1016/S0140-6736(19)30654-3. Epub 2019 May 16. PMID: 31104833; PMCID: PMC7179969.
* Rush ET, Johnson B, Aradhya S, Beltran D, Bristow SL, Eisenbeis S, Guerra NE, Krolczyk S, Miller N, Morales A, Ramesan P, Sarafrazi S, Truty R, Dahir K. Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program. J Bone Miner Res. 2022 Feb;37(2):202-214. doi: 10.1002/jbmr.4454. Epub 2021 Nov 10. PMID: 34633109; PMCID: PMC9298723.
* Chinoy A, Padidela R. Refractory Rickets. Indian J Pediatr. 2023 Jun;90(6):574-581. doi: 10.1007/s12098-023-04538-4. Epub 2023 Apr 19. PMID: 37074534; PMCID: PMC10212799.
* Ito N, Hidaka N, Kato H. The pathophysiology of hypophosphatemia. Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101851. doi: 10.1016/j.beem.2023.101851. Epub 2023 Nov 30. PMID: 38087658.
* Haffner D, Emma F, Seefried L, Högler W, Javaid KM, Bockenhauer D, Bacchetta J, Eastwood D, Biosse Duplan M, Schnabel D, Wicart P, Ariceta G, Levtchenko E, Harvengt P, Kirchhoff M, Gardiner O, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenický P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2025 May;21(5):330-354. doi: 10.1038/s41581-024-00926-x. Epub 2025 Jan 15. PMID: 39814982.
* Ali DS, Carpenter TO, Imel EA, Ward LM, Appelman-Dijkstra NM, Chaussain C, Jan de Beur SM, Florenzano P, Abu Alrob H, Aldabagh R, Alexander RT, Alsarraf F, Beck-Nielsen SS, Biosse-Duplan M, Crowley RK, Dandurand K, Filler G, Friedlander L, Fukumoto S, Gagnon C, Goodyer P, Grasemann C, Grimbly C, Hussein S, Javaid MK, Khan S, Khan A, Lehman A, Lems WF, Lewiecki EM, McDonnell C, Mirza RD, Morgante E, Morrison A, Portale AA, Rao C, Rhee Y, Rush ET, Siggelkow H, Tetradis S, Tosi L, Guyatt G, Brandi ML, Khan AA. X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline. J Clin Endocrinol Metab. 2025 Jun 17;110(7):2055-2070. doi: 10.1210/clinem/dgaf093. PMID: 39960858; PMCID: PMC12187519.
* Khan AA, Ali DS, Appelman-Dijkstra NM, Carpenter TO, Chaussain C, Imel EA, Jan de Beur SM, Florenzano P, Abu Alrob H, Aldabagh R, Alexander RT, Alsarraf F, Beck-Nielsen SS, Biosse-Duplan M, Cohen-Solal M, Crowley RK, Dandurand K, Filler G, Friedlander L, Fukumoto S, Gagnon C, Goodyer P, Grasemann C, Grimbly C, Hussein S, Javaid MK, Khan S, Khan A, Lehman A, Lems WF, Lewiecki EM, McDonnell C, Mirza RD, Morgante E, Morrison A, Portale AA, Rhee Y, Rush ET, Siggelkow H, Tetradis S, Tosi L, Ward LM, Guyatt G, Brandi ML. X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline. J Clin Endocrinol Metab. 2025 Jul 15;110(8):2353-2370. doi: 10.1210/clinem/dgaf170. PMID: 40243526; PMCID: PMC12261105.
* Böckmann I, Haffner D. The Diagnosis and Therapy of XLH. Calcif Tissue Int. 2025 Apr 28;116(1):66. doi: 10.1007/s00223-025-01374-w. Epub 2025 Apr 28. PMID: 40295317; PMCID: PMC12037658.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.